Skip to Content

ACCL1931, A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy

Phase III Clinical Trial

Indication: Leukemia
Trial Number: 05602194
Trial Status: OPEN

Participating Locations